Skip to main content
. 2012 Feb;50(2):388–395. doi: 10.1128/JCM.05392-11

Table 1.

Sociodemographic and clinical characteristics of included TB cases and comparison between clustered and nonclustered (unique) TB cases, Switzerland, 2000 to 2008

Characteristic Value for:
All cases (n = 520) Clustered cases (n = 90) Unclustered cases (n = 430)
Median age (yr) at TB diagnosis (IQR) 36.5 (28–51) 36 (27–45) 37 (29–53)
No. (%) of males 254 (48.9) 47 (52.2) 207 (48.1)
No. (%) born in:
    Switzerland 119 (22.9) 23 (25.6) 96 (22.3)
    Other Europe 106 (20.4) 17 (18.9) 89 (20.7)
    Sub-Saharan Africa 132 (25.4) 33 (36.7) 99 (23.0)
    Asia 120 (23.1) 12 (13.3) 108 (25.1)
    Central/South America 20 (3.8) 3 (3.3) 17 (4.0)
    Other regions/unknown 23 (4.4) 2 (2.2) 21 (4.9)
No. (%) of:
    Swiss nationals 130 (25.0) 19 (21.1) 111 (25.8)
    Foreigners, residents 140 (26.9) 18 (20.0) 122 (28.4)
    Foreigners, othera 59 (11.3) 13 (14.4) 46 (10.7)
    Asylum seekers/refugees 101 (19.4) 21 (23.3) 80 (18.6)
    Unknown 90 (17.3) 19 (21.1) 71 (16.5)
No. (%)
    HIV infected 113 (21.7) 21 (23.3) 92 (21.4)
    HIV negative 407 (78.3) 69 (76.7) 338 (78.6)
No. (%) with immunosuppression other than due to HIV infectionb 32 (6.2) 8 (8.9) 24 (5.6)
No. (%) with:
    Previous TB diagnosis 50 (9.6) 8 (8.9) 42 (9.8)
    No previous TB diagnosis 300 (57.7) 50 (55.6) 250 (58.1)
    Unknown 170 (32.7) 32 (35.6) 138 (32.1)
No. (%) with positive smear result 168 (32.3) 38 (42.2) 130 (30.2)
No. (%) with cavitary disease 113 (21.7) 27 (30.0) 86 (20.0)
No. (%) with clinical manifestation
    Pulmonary 387 (74.4) 72 (80.0) 315 (73.3)
    Extrapulmonary 133 (25.6) 18 (20.0) 115 (26.7)
No. (%) with TB in family or social surroundings in last 2 yr 38 (7.3) 11 (12.2) 27 (6.3)
a

Visitors, students, etc.

b

Use of anti-tumor necrosis factor (anti-TNF) blockers, malignancy, organ transplantation, use of steroids or methotrexate.